Kanagawa, Japan

Rie Iwata

USPTO Granted Patents = 3 



Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Asaka, JP (2010)
  • Kanagawa, JP (2018 - 2019)

Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rie Iwata: Innovator in Stem Cell Research

Introduction

Rie Iwata is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of stem cell research, holding a total of 3 patents. Her work focuses on innovative methods and compositions that advance the understanding and application of pluripotent stem cells.

Latest Patents

Rie Iwata's latest patents include a method of culturing pluripotent stem cells and a polypeptide designed for use in this process. The polypeptide features a first region that contains specific amino acid sequences, including CSYYQSC and RGD. Additionally, it has a second region that includes various amino acid sequences with specific properties related to cultivation containers. Another notable patent involves a polypeptide that contributes to cartilage tissue restoration and promotes glycosaminoglycan production, showcasing her commitment to advancing medical science.

Career Highlights

Rie Iwata is currently employed at Fujifilm Corporation, where she continues to innovate and develop new technologies. Her work has garnered attention in the scientific community, and she is recognized for her contributions to regenerative medicine.

Collaborations

Rie collaborates with talented individuals such as Hiroko Inomata and Yuta Murakami, enhancing her research efforts and broadening the impact of her inventions.

Conclusion

Rie Iwata's innovative work in stem cell research and her impressive portfolio of patents highlight her as a leading figure in her field. Her contributions are paving the way for advancements in medical treatments and regenerative therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…